These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32909330)

  • 1. Proton pump inhibitors and chronic kidney disease: Reevaluating the evidence from a randomized controlled trial.
    Gerstman BB
    Pharmacoepidemiol Drug Saf; 2021 Jan; 30(1):4-8. PubMed ID: 32909330
    [No Abstract]   [Full Text] [Related]  

  • 2. Is red meat consumption the confounding factor explaining the association between chronic kidney disease and proton pump inhibitors?
    Desbuissons G; Mercadal L
    Nephrol Ther; 2019 Jul; 15(4):191-192. PubMed ID: 31056405
    [No Abstract]   [Full Text] [Related]  

  • 3. Proton pump inhibitors and chronic kidney disease: is it time to sound the alarm?
    Wyatt CM
    Kidney Int; 2016 Apr; 89(4):732-3. PubMed ID: 26994567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of proton pump inhibitors and chronic kidney disease: cause or confounding?
    Li T; Xie Y; Al-Aly Z
    Curr Opin Nephrol Hypertens; 2018 May; 27(3):182-187. PubMed ID: 29432214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.
    Moayyedi P; Eikelboom JW; Bosch J; Connolly SJ; Dyal L; Shestakovska O; Leong D; Anand SS; Störk S; Branch KRH; Bhatt DL; Verhamme PB; O'Donnell M; Maggioni AP; Lonn EM; Piegas LS; Ertl G; Keltai M; Bruns NC; Muehlhofer E; Dagenais GR; Kim JH; Hori M; Steg PG; Hart RG; Diaz R; Alings M; Widimsky P; Avezum A; Probstfield J; Zhu J; Liang Y; Lopez-Jaramillo P; Kakkar AK; Parkhomenko AN; Ryden L; Pogosova N; Dans AL; Lanas F; Commerford PJ; Torp-Pedersen C; Guzik TJ; Vinereanu D; Tonkin AM; Lewis BS; Felix C; Yusoff K; Metsarinne KP; Fox KAA; Yusuf S;
    Gastroenterology; 2019 Sep; 157(3):682-691.e2. PubMed ID: 31152740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors are associated with risk of chronic kidney disease, study finds.
    Wise J
    BMJ; 2016 Jan; 352():i128. PubMed ID: 26759185
    [No Abstract]   [Full Text] [Related]  

  • 7. The relationship between proton pump inhibitors and renal disease.
    Morschel CF; Mafra D; Eduardo JCC
    J Bras Nefrol; 2018; 40(3):301-306. PubMed ID: 30010692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association Between Proton Pump Inhibitor Use With Acute Kidney Injury and Chronic Kidney Disease.
    Kamal F; Khan MA; Molnar MZ; Howden CW
    J Clin Gastroenterol; 2018 Jul; 52(6):468-476. PubMed ID: 29668562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do Proton-Pump Inhibitors Cause CKD and Progression of CKD?: PRO.
    Awdishu L; Abagyan R
    Kidney360; 2022 Jul; 3(7):1134-1136. PubMed ID: 35919519
    [No Abstract]   [Full Text] [Related]  

  • 10. Do Proton-Pump Inhibitors Cause CKD and Progression of CKD?: COMMENTARY.
    Paueksakon P; Fogo AB
    Kidney360; 2022 Jul; 3(7):1141-1143. PubMed ID: 35920527
    [No Abstract]   [Full Text] [Related]  

  • 11. Adverse Effects Associated With Proton Pump Inhibitors.
    Schoenfeld AJ; Grady D
    JAMA Intern Med; 2016 Feb; 176(2):172-4. PubMed ID: 26751904
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of proton pump inhibitors and the risk of chronic kidney disease].
    Divisón Garrote JA; Escobar Cervantes C
    Semergen; 2017 Apr; 43(3):230-231. PubMed ID: 27132589
    [No Abstract]   [Full Text] [Related]  

  • 13. Do Proton-Pump Inhibitors Cause CKD and Progression of CKD?: CON.
    Cholin L; Nakhoul G
    Kidney360; 2022 Jul; 3(7):1137-1140. PubMed ID: 35919541
    [No Abstract]   [Full Text] [Related]  

  • 14. Proton-pump inhibitors and chronic kidney disease: Hidden consequences of an inappropriate drug use?
    Schiffl H; Al-Nemnem E; Lang SM
    Saudi J Kidney Dis Transpl; 2020; 31(2):312-319. PubMed ID: 32394903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of Proton Pump Inhibitors Questioned Based on a Large Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.
    Simin J; Liu Q; Fornes R; Brusselaers N
    Gastroenterology; 2020 Mar; 158(4):1172-1173. PubMed ID: 31836528
    [No Abstract]   [Full Text] [Related]  

  • 16. Using proton pump inhibitors correlates with an increased risk of chronic kidney disease: a nationwide database-derived case-controlled study.
    Hung SC; Liao KF; Hung HC; Lin CL; Lai SW; Lee PC; Hung SR
    Fam Pract; 2018 Mar; 35(2):166-171. PubMed ID: 29045621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPIs: adding (airway) insult to (kidney) injury?
    The Lancet Gastroenterology Hepatology
    Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):145. PubMed ID: 28404120
    [No Abstract]   [Full Text] [Related]  

  • 18. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
    Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
    JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients.
    Lee HJ; Lee H; Oh SH; Park J; Park S; Jeon JS; Noh H; Han DC; Kwon SH
    PLoS One; 2018; 13(9):e0203878. PubMed ID: 30212538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Not Available].
    Steurer J
    Praxis (Bern 1994); 2016 Apr; 105(8):471-2. PubMed ID: 27078733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.